Regulatory Action In France Due To Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Cases (Posted by Tom Lamb at DrugInjuryWatch.com) There have been more than 600 cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) reported worldwide, which is a type of non-Hodgkin's lymphoma. In December 2018 France’s National Agency for the Safety of Medicines and Health Products (ANSM) announced that Allergan’s textured breast implants can no longer be marketed in France and Europe. From this December 20, 2018 news report, "Allergan Textured Breast Implant Sales Halted in Europe Amid Safety Controversy", we get these details about this breast implants recall: Allergan, one of the world’s largest manufacturers of breast implants, has been blocked from selling several popular products in Europe amid growing concerns over a link to a rare form of cancer. The company has been unable to renew safety…
Read more detail on Recent Products Liability posts –
